Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation
Open Access
- 28 March 1999
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 29 (3) , 815-822
- https://doi.org/10.1002/(sici)1521-4141(199903)29:03<815::aid-immu815>3.0.co;2-8
Abstract
C3b and C5b deposition following complement activation, and its regulation by CD46 were studied using xenogenic Chinese hamster ovary (CHO) cells as targets and cytofluorometry. Following activation of the alternative pathway, an initial low level of C3b deposition was observed on CHO cell surfaces after a lag time of approximately 4 min. This was followed by a secondary high level of C3b deposition with a slower rate. C3b deposition was maximal within 15 min. When CD46 was expressed (B2 isoform), the kinetics of C3b deposition were essentially unchanged, but the onset of the secondary high C3b deposition was fully prevented. C5b deposition was also observed on CHO but not an CHO.CD46 cells following activation of the alternative pathway. Activation of the classical pathway on CHO and CHO.CD46 cells, using factor B-depleted human serum and anti-CHO antibodies, resulted in almost identical single-peak C3b deposition profiles. Accordingly, no regulation of C5b deposition by CD46 was evident following activation of the classical pathway. These data indicate that CD46 prevents the C3b deposition amplification loop mediated by the alternative C3 convertase and, consequently, inhibits the formation of the alternative C5 convertase. But CD46 prevents neither the spontaneous tick-over C3b deposition leading to the formation of the alternative C3 convertase nor the formation of the functional classical C3 and C5 convertases.Keywords
This publication has 25 references indexed in Scilit:
- A second serine protease associated with mannan-binding lectin that activates complementNature, 1997
- Mode of entry of morbillivirusesVeterinary Microbiology, 1995
- Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement mediated lysisTransplant Immunology, 1993
- A Monoclonal Antibody Recognizes a Human Cell Surface Glycoprotein Involved In Measles Virus BindingJournal of General Virology, 1992
- Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism.The Journal of Experimental Medicine, 1992
- Regulatory system of guinea-pig complement C3b: Tests for compatibility of guinea-pig factors H and I with human factorsMolecular Immunology, 1991
- Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).The Journal of Experimental Medicine, 1990
- Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.The Journal of Experimental Medicine, 1986
- Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.The Journal of Experimental Medicine, 1982
- Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.The Journal of Experimental Medicine, 1981